Bone Biologics (NASDAQ: BBLG ) stock is falling on Friday after the medical device company's shares underwent a major rally the day prior. That rally was caused by heavy trading of BBLG stock.
Bone Biologics (NASDAQ: BBLG ) stock is rocketing higher despite a lack of news from the medical device company on Thursday. There are no new press releases or filings with the Securities and Exchange Commission that explain why BBLG stock is up today.
Most traders dream of hitting it big, and penny stocks are some of the most attractive for day traders. It can be any given session where we see at least a handful of cheap stocks under $5 explode.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Shares of Bone Biologics Corp. BBLG plummeted 51.9% toward a record low in premarket trading Thursday, after the developer of regenerative medicine for bones announced the pricing of its relatively large stock offering at a deep discount. The company raised $5 million, as it said overnight that it sold 2.54 million shares, which represented 15.2% of the shares outstanding, at price of $1.97 per share.
Bone Biologics (NASDAQ: BBLG ) stock is breaking down on Thursday after the company announced the details of a public share offering. Bone Biologics has revealed its public offering prices shares of BBLG stock at $1.97 each.